Skip to main content
. Author manuscript; available in PMC: 2016 May 9.
Published in final edited form as: Vaccine. 2011 Sep 3;29(46):8302–8308. doi: 10.1016/j.vaccine.2011.08.093

Table 4.

H1N1 case reports submitted to CISA with documented concurrent infections

Diagnosis Infectious etiology Testing
Encephalitis Influenza, type A Nasopharyngeal rapid test positive
Acute Demyelinating Encephalomyelitis Parainfluenza PCR nasopharyngeal positive
Acute Demyelinating Encephalomyelitis Parainfluenza Positive culture nasal wash
Seizure H1N1 influenza, wild type Nasal swab culture positive
Demyelinating Disorder of Unclear Etiology Hepatitis B Previously diagnosed
Demyelinating Disorder of Unclear Etiology Mycoplasma Serum IgM positive
Seizure Group A Streptococcus Positive culture
Bell’s Palsy Herpes Simplex Virus Unknown test
Encephalitis Mycoplasma and Enterovirus IgM positive
Transverse Myelitis Mycoplasma Serum Mycoplasma IgM and IgG positive
GBS, Brighton level 2 a Group A Streptococcus Rapid antigen detection test positive
GBS, Brighton level 2 a Pneumococcus Positive blood culture
GBS, Brighton level 2 a Mycoplasma “Serum Reactive” IgM
GBS, Brighton level 2 a Borrelia burgdorferi Positive antibody screen and western blot
GBS, Brighton level 2 a Epstein Barr Virus EBV IgM positive serum
GBS, Brighton level 2 a Enterovirus Positive PCR in CSF
GBS, Brighton level 1 a Cytomegalovirus Serum IgM and IgG positive
GBS, Brighton level 1 a Cytomegalovirus CSF and serum DNA positive
GBS, physician diagnosed Human Immunodeficiency Virus Previously diagnosed
a

Brighton Collaboration [10]